Log In
Print this Print this

RedoxSYS Diagnostic System

  Manage Alerts
Collapse Summary General Information
Company Ampio Pharmaceuticals Inc.
DescriptionBlodd based diagnostic that measures oxidation-reduction potential (ORP) in the body
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics: Other diagnostic technologies
Latest Stage of DevelopmentPreclinical
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose the impact of development-stage antioxidant therapies on reducing oxidative stress in neurodegenerative diseases
Regulatory Designation
PartnerAytu BioScience Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today